Target
$77.80 → $77.86
Current stock research snapshot · 7/8/26 49 days old
TECHBio-Techne
Investment conviction●●○○○2 of 5 · current snapshot
Research target$77.86Current stock price target
Investment thesis statusINTACTLast reviewed 7/8/26
Market cap$11.00BSnapshot value · 7/8/26
Research history
See all TECH changes ↗What changed
Reagents + instruments + bioprocessing services. Straddles Measure (reagents/instruments) and Manufacture (bioprocessing consumables). Recurring consumable pull.
Bioprocess cycle recovery; biopharma R&D spending; GMP-grade reagent demand for manufacturing.
Multi-layer exposure means neither pure-play premium nor full diversification benefit; bioprocess cyclicality; smaller scale vs TMO/DHR.
Neutral — No investor/analyst mentions of the company found. [X search Aug 2026]
Snapshot · 7/8/26🟢 Lean-Bull · ins-$0.3M · 13F 18+/7-×0.5 · short↓0.08
Snapshot · 7/8/26